An observational study in Rotavirus Gastroenteritis, sponsored by Society for Applied Studies. Completed at 1 site in India. Open to participants aged 1 Day to 24 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-01-12.
Sponsored by Society for Applied Studies · Observational
This study was designed to support site preparation and to conduct a disease burden study for the planning and implementation of the phase III trials for the oral rotavirus vaccine 116E.
Field workers conducted weekly surveillance in areas allocated to them and identified pregnant women, newborns and infants aged 9 to 12 months. Children who were eligible for participation through criteria for inclusion and exclusion in the trial were enrolled. Two cohorts were recruited, one cohort enrolled within one week of birth and followed up weekly till 1 year of age (cohort 1=100) and the second cohort enrolled at 12 months of age and followed up till 24 months of age (cohort 2=100).
Weekly contact were made by field workers for both the cohorts. At each contact cases of gastroenteritis were identified. All infants with gastroenteritis were assessed by a field worker/clinical coordinator. The child was assessed for presence of dehydration, danger signs. The field worker/clinical coordinator ensured that at least one diarrheal stool specimen was collected for each episode of gastroenteritis. Infants were treated at the study clinic or escorted to one of the identified hospitals, if required.
Caregivers of the enrolled infants were explained the signs and symptoms of suspected intussusception, dehydration and danger signs that require hospital referral and were given the option to seek care from the study clinic or from one of the identified hospitals in the vicinity.
Stool specimens were collected in all diarrheal episodes. In a subset of 30 children who were identified early in a diarrheal episode and who shed rotavirus, multiple stool specimens were collected in order to assess duration of shedding of rotavirus during a natural infection.
The study was also designed to collect information on data essential for planning and implementation of phase III trials pertaining to trial logistics, data collection tools and validity of questions including those in the Vesikari score.
Society for Applied Studies is the lead sponsor of 21 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
This study was conducted in Delhi at Govindpuri-Tigri-Dakshinpuri, Tuglakabad and Sangam Vihar.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Cohort 1: Infants enrolled at ≤1 week and followed up weekly till one year of age.
Cohort 2: Infants enrolled at 12 months and followed up weekly till they are aged 24 months.
Disease burden
All episodes of gastroenteritis: * rotavirus gastroenteritis * rotavirus gastroenteritis by the G and P types * severe gastroenteritis * severe rotavirus gastroenteritis * severity score of all episodes of gastroenteritis Rates of hospitalization in the above categories Proportion requiring rehydration therapy in all the above categories
Time frame: 1 year
Duration of rotavirus shedding
To ascertain the duration of rotavirus shedding after an episode of rotavirus gastroenteritis
Time frame: 1 year
Rotavirus genotypes
To identify genotypes of rotavirus
Time frame: 1 year
Data collection for planning and implementation of phase III trials
To collect information on data essential for planning and implementation of phase III trials pertaining to trial logistics, data collection tools and validity of questions including those in the Vesikari score.
Time frame: 1 year
This study is completed, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Society for Applied Studies